ClinicalTrials.Veeva

Menu

Lactate Metabolism After an Endotoxin Challenge in Healthy Humans

U

University of Lausanne (UNIL)

Status

Completed

Conditions

Sepsis

Treatments

Other: bacterial endotoxin challenge

Study type

Interventional

Funder types

Other

Identifiers

NCT01647997
Lsne-128/01

Details and patient eligibility

About

Sepsis is characterized by hyperlactatemia, the severity of which is proportionate with sepsis severity. The pathophysiological mechanisms (increased lactate production vs decreased lactate utilization; tissues involved in sepsis-induced lactate production) remain largely unknown.

In this study, the investigators will assess whole body and regional metabolism in healthy young male subjects on two occasions, once after administration of an intravenous bacterial endotoxin challenge, and once without intervention.

In one group of subjects, whole body lactate metabolism will be measured over 10 hours after the endotoxin challenge

  • Energy expenditure and net substrate oxidation rates (indirect calorimetry)
  • Lactate kinetics (measured by means of a continuous, exogenous sodium lactate infusion)
  • Glucose kinetics (measured with 6,6 d2 glucose)
  • Hemodynamic parameters and body temperature
  • Blood clinical chemistry In one group of subjects, whole body lactate metabolism will be measured over 10 hours after the endotoxin challenge
  • Energy expenditure and net substrate oxidation rates (indirect calorimetry)
  • Lactate kinetics (measured by means of a continuous, exogenous sodium lactate infusion)
  • Glucose kinetics (measured with 6,6 d2 glucose)
  • Hemodynamic parameters and body temperature
  • Blood clinical chemistry

In a second group of subjects, regional muscle lactate metabolism will be measured over 10 hours after the endotoxin challenge by means of muscle microdialysis

Enrollment

14 patients

Sex

Male

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • gender male
  • body mass index (BMI) < 25 kg/m2
  • absence of known disease

Exclusion criteria

  • any known pathology
  • abnormal cardio-pulmonary and hemodynamic status
  • electrocardiographic alterations
  • history of allergy
  • current medications
  • drug abuse
  • consumption of more than 20g/day alcohol

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

14 participants in 4 patient groups

study 1a
Experimental group
Description:
whole body lactate production after bacterial endotoxin challenge
Treatment:
Other: bacterial endotoxin challenge
study 1b
No Intervention group
Description:
basal whole body lactate production
study 2a
Experimental group
Description:
muscle lactate concentration after bacterial endotoxin challenge
Treatment:
Other: bacterial endotoxin challenge
study 2b
No Intervention group
Description:
basal muscle lactate concentrations

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems